LiverLearning®

Resources

AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.

For more information on the Practice Guidelines and Guidances, please visit the AASLD Practice Guidelines and Guidances webpage


  • AASLD 2018 Hepatitis B Guidance
    The 2018 updated guidance on chronic hepatitis B (CHB) includes (1) updates on treatment since the 2016 HBV guidelines (notably the use of tenofovir alafenamide) and guidance on (2) screening, counseling, and prevention; (3) specialized virological and serological tests; (4) monitoring of untreated patients; and (5) treatment of hepatitis B in special populations, including persons with viral coinfections, acute hepatitis B, recipients of immunosuppressive therapy, and transplant recipients.
  • AASLD 2018 Hepatocellular Carcinoma Guidelines
    This document presents official recommendations of the American Association for the Study of Liver Diseases (AASLD) on the surveillance, diagnosis, and treatment of hepatocellular carcinoma (HCC) occurring in the setting of adults with cirrhosis.
  • AASLD 2018 NAFLD Guidance
    This guidance provides a data‐supported approach to the diagnostic, therapeutic, and preventive aspects of nonalcoholic fatty liver disease (NAFLD) care.
  • AASLD 2016 Portal Hypertensive Bleeding in Cirrhosis Guidance
    This guidance provides a data‐supported approach to risk stratification, diagnosis, and management of patients with cirrhosis and portal hypertension (PH).
  • AASLD 2015 Hepatitis B, Chronic Guidelines
    Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis
  • AASLD 2015 Hepatitis B, Chronic Guidelines
    Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta‐analysis
  • AASLD 2015 Hepatitis B, Chronic Guidelines
    Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis
  • AASLD 2015 Hepatitis B, Chronic Guidelines
    AASLD Guidelines for Treatment of Chronic Hepatitis B
  • AASLD 2014 Hepatic Encephalopathy Guidelines
    AASLD 2014 Hepatic Encephalopathy Guidelines
  • AASLD 2014 Hepatitis C, Guidance
    AASLD 2014 Hepatitis C, Guidance
  • AASLD 2014 Liver Transplantation, Evaluation of the pediatric patient Guidelines
    AASLD 2014 Liver Transplantation, Evaluation of the pediatric patient
  • AASLD 2014 Liver Transplantation, Evaluation of the adult patient Guidelines
    AASLD 2014 Liver Transplantation, Evaluation of the adult patient
  • AASLD 2013 Ascites due to cirrhosis, Management Guidelines
    AASLD 2013 Ascites due to cirrhosis, Management
  • AASLD 2013 Long-Term Medical Management of the Pediatric Patient After Liver Transplantation Guidelines
    AASLD 2013 Long-Term Medical Management of the Pediatric Patient After Liver Transplantation
  • AASLD 2012 Long-Term Management of the Successful Adult Liver Transplant Guidelines
    AASLD 2012 Long-Term Management of the Successful Adult Liver Transplant
  • AASLD 2011 Acute Liver Failure, Management Guidelines
    The present version of the American Association for the Study of Liver Diseases (AASLD) Position Paper represents a thorough overhaul from the previous version of 2005. In addition to two new additional authors, the revision includes updated expert opinion regarding (1) etiologies and diagnosis, (2) therapies and intensive care management, and (3) prognosis and transplantation. We offer three publications:
  • AASLD 2011 Hemochromatosis, Management Guidelines
    AASLD 2011 Hemochromatosis, Management Guidelines
  • AASLD 2010 Primary Sclerosing Cholangitis, Management Guidelines
    AASLD 2010 Primary Sclerosing Cholangitis, Management
  • AASLD 2010 Autoimmune Hepatitis, Management Guidelines
    AASLD 2010 Autoimmune Hepatitis, Management Guidelines
  • AASLD 2009 Alcoholic Liver Disease Guidelines
    Robert S. O’Shea, Srinivasan Dasarathy, Arthur J. McCullough, and the Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology.